People: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

93.35USD
2 Sep 2015
Change (% chg)

-- (--)
Prev Close
$93.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,704,302
52-wk High
$109.49
52-wk Low
$81.79

Search Stocks

McClellan, Mark 

Dr. Mark B. McClellan, M.D., Ph.D. is a Independent Director of Johnson & Johnson. He joined the Board of Directors in 2013, and is a member of the Regulatory, Compliance & Government Affairs Committee, and the Science, Technology & Sustainability Committee. He currently is a Senior Fellow in Economic Studies, and Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution, which he joined in 2007, following a year as a visiting senior fellow at the American Enterprise Institute-Brookings Joint Center for Regulatory Studies. As former commissioner of the U.S. Food and Drug Administration from 2002 to 2004, and as the former administrator of the Centers for Medicare & Medicaid Services for the U.S. Department of Health and Human Services from 2004 to 2006, Dr. McClellan has more than two decades of public service and academic research experience. From 2001 to 2002, he served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House. During President William J. Clinton’s administration, Dr. McClellan held the position of deputy assistant secretary of the Treasury for economic policy. Dr. McClellan previously served as an associate professor of economics and medicine with tenure at Stanford University, where he also directed the Program on Health Outcomes Research.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky

24,989,300

Dominic Caruso

10,349,000

Sandra Peterson

7,086,610

Paulus Stoffels

18,339,300

Michael Ullmann

5,960,690

Peter Fasolo

3,621,280
As Of  27 Dec 2014
Search Stocks